Disrupting Eyewear Through Omnichannel Retail and Vertical Integration

Warby Parker Inc. is a direct-to-consumer eyewear company that disrupted the traditional optical industry with its pioneering "buy a pair, give a pair" social mission and vertically integrated business model. Founded in 2010 and headquartered in New York City, the company went public via a direct listing on the NYSE in September 2021.

The company generates revenue through two primary channels: (1) direct-to-consumer e-commerce via its website and mobile app, and (2) physical retail stores across the United States and Canada. Its product portfolio includes prescription eyeglasses, sunglasses, contact lenses, and eye exams conducted at its retail locations. Warby Parker's customer base spans over 2.5 million active customers, with an average order value of approximately $220.

The company's scale is substantial: over 280 retail stores, a proprietary lens manufacturing facility in Las Vegas, and a supply chain that produces more than 8 million pairs of glasses annually. Warby Parker employs approximately 5,000 people, including licensed optometrists who staff its in-store eye exam services — a high-margin ancillary revenue stream that also serves as a customer acquisition funnel.

• Near-Term (FY2026-FY2027): Warby Parker projects 12-14% revenue growth, driven by the opening of 40-45 new stores annually and continued e-commerce penetration. The company's contact lens business, launched in 2019, is growing at 30%+ year-over-year and represents a significant cross-selling opportunity given the recurring nature of contact lens purchases.

• Medium-Term (FY2028-FY2030): Management targets a $3B revenue run-rate by 2030, implying a compound annual growth rate of approximately 15%. Key drivers include: (1) expanding into new geographies, particularly the Southeast and Midwest where the company currently has limited presence, (2) launching international operations in Canada and the UK, and (3) deepening insurance partnerships to capture a larger share of the $60B+ vision care market.

• Margin Expansion Catalysts: As store cohorts mature, the company expects operating leverage to drive adjusted EBITDA margins from ~14.5% in FY2026 toward 18-20% by FY2028. The proprietary lens manufacturing plant, which currently produces 40% of the company's lenses, is slated to increase that figure to 70% by 2027, generating an estimated 200-300 basis points of gross margin improvement.

Warby Parker's financial trajectory reflects a deliberate transition from growth-at-all-costs to disciplined, profitable expansion. Revenue growth has normalized from the pandemic-era highs to a sustainable 12-14% range, while gross margins have steadily expanded by 60-80 basis points annually — a direct result of in-sourcing lens production and negotiating better frame manufacturing terms.

The company achieved GAAP profitability in FY2025 for the first time as a public company, with EPS of $0.02, and we project continued earnings growth to $0.28 by FY2027. Adjusted EBITDA margins are expanding at a rate of roughly 100 basis points per year, driven by store maturation, fixed-cost leverage in the supply chain, and a favorable product mix shift toward higher-margin proprietary lenses and contact lenses. The balance sheet remains healthy with approximately $250M in cash and no meaningful debt, providing ample liquidity to fund the store expansion program.

The U.S. eyewear market is valued at approximately $45B annually, encompassing prescription glasses, sunglasses, contact lenses, and eye exams. The broader global vision care market exceeds $150B. Warby Parker's serviceable addressable market, including insured customers, is estimated at $60B+.

The industry has historically been dominated by EssilorLuxottica, the vertically integrated Italian-French conglomerate that controls roughly 40% of the global eyewear market through brands like Ray-Ban, Oakley, and retail chains including LensCrafters, Sunglass Hut, and Target Optical. However, the competitive landscape has fragmented significantly over the past decade with the rise of digitally native brands.

Warby Parker's competitive positioning is strongest in the "affordable premium" segment — offering designer-quality frames at $95-$195, undercutting traditional retail prices by 40-60% while maintaining a superior brand experience. The company's primary competitive threats come from EssilorLuxottica's aggressive push into e-commerce and National Vision's low-price leadership. However, Warby Parker's unique combination of physical retail presence, brand equity, and technology infrastructure creates meaningful barriers to entry that pure-play e-commerce competitors like Zenni struggle to replicate.

Discounted Cash Flow Analysis: We employ a 10-year DCF model with the following assumptions: (1) revenue growing at a 12% CAGR through FY2030 before decelerating to 5% terminal growth, (2) adjusted EBITDA margins expanding to 20% by FY2032, (3) a 7% discount rate reflecting the company's low leverage and improving profitability, and (4) a 1.5% terminal growth rate. This analysis yields an intrinsic value of approximately $31 per share, implying the stock is undervalued by roughly 30% at its current price of $23.73.

Comparable Company Analysis:

Warby Parker trades at a significant premium to traditional optical retailers like National Vision, reflecting its superior growth profile and brand strength. However, on an EV/EBITDA basis, the stock is actually cheaper than high-growth e-commerce peers like Chewy, despite Warby Parker's stronger gross margins and clearer path to sustained profitability. Our blended valuation — weighting the DCF at 60% and comparable company analysis at 40% — supports a fair value of $29-33 per share, with our $32 price target representing the midpoint of this range.

• Intense Competitive Pressure: EssilorLuxottica's scale advantages and aggressive pricing in the value segment could compress Warby Parker's margins. The company's premium valuation leaves little room for error if growth decelerates below the 10-12% range due to competitive share loss.

• High Short Interest and Volatility: With 20.84% of float shorted and a beta of 1.91, WRBY is susceptible to extreme price swings. Negative earnings surprises or guidance cuts could trigger cascading sell-offs, while positive catalysts may cause rapid short squeezes — creating an unpredictable trading environment unrelated to fundamentals.

• Store Expansion Execution Risk: The company's growth strategy relies heavily on opening 40-45 new stores annually. Failure to find suitable locations, rising commercial real estate costs, or cannibalization of existing store sales could impair the return on invested capital and slow the path to margin expansion.

• Dependence on China-Based Manufacturing: While Warby Parker has diversified its supply chain, a significant portion of its frames are still manufactured in China. Tariff escalation, supply chain disruptions, or geopolitical tensions could increase cost of goods sold and pressure the company's 56-58% gross margins.

• Regulatory and Policy Risk: Changes to vision insurance reimbursement rates, particularly under Medicare/Medicaid expansion scenarios, could impact the company's insured customer segment. Additionally, any federal or state-level price controls on healthcare services could affect the profitability of its eye exam business.